Relationship between serum cystatin C and hypertension among US adults without clinically recognized chronic kidney

Anoop Shankar1, Srinivas Teppala

  • 1Department of Community Medicine, West Virginia University School of Medicine, Morgantown, WV, USA. ashankar@hsc.wvu.edu

Insights

Mildly reduced kidney function, indicated by higher serum cystatin C, is linked to hypertension in women but not men, even before chronic kidney disease (CKD) is clinically apparent.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Animal studies suggest a link between reduced renal function and hypertension.
  • Few human studies have investigated this association, particularly in individuals without clinically recognized chronic kidney disease (CKD).
  • Serum cystatin C is a marker of glomerular filtration rate (GFR).

Purpose of the Study:

  • To examine the association between serum cystatin C levels and hypertension in US adults without clinically recognized CKD.
  • To determine if this association differs between men and women.

Main Methods:

  • Analysis of data from the National Health and Nutrition Examination Survey (1999-2002) on 2583 US adults (>20 years).
  • Exclusion of participants with estimated GFR <60 mL/min/1.73 m² or microalbuminuria.
  • Hypertension defined by medication use or blood pressure thresholds (≥140/90 mm Hg).
  • Serum cystatin C levels categorized into quartiles; multivariable adjustments performed.

Main Results:

  • Higher serum cystatin C levels were significantly associated with hypertension in women (OR 2.04, 95% CI 1.13-3.69 for Q4 vs Q1; P trend = .02).
  • No significant association was found between serum cystatin C levels and hypertension in men (OR 0.86, 95% CI 0.53-1.41; P trend = .51).
  • These findings persisted after adjusting for multiple confounding factors.

Conclusions:

  • Mildly reduced kidney function, as indicated by elevated serum cystatin C, is associated with hypertension in US women without clinically recognized CKD.
  • This association was not observed in men.
  • Serum cystatin C may serve as an early indicator of hypertension risk in women, independent of established CKD markers.

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...